已选(0)清除
条数/页: 排序方式:
|
| All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文 作者: Wei, Lai; Xu, Xiaoyuan; Guan, Yujuan; Zheng, Sujun; Sheng, Ji-Fang
![](/themes/default/image/downing1.png) 收藏  |  浏览/下载:46/0  |  提交时间:2019/12/05 |
| Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文 作者: Wei, Lai; Xu, Xiaoyun; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang
![](/themes/default/image/downing1.png) 收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05 |
| Efficacy and safety of omalizumab in Chinese patients with moderate to severe asthma: a randomised phase 3 study 会议论文 作者: Jing Li; Jian Kan; Chang ZhengWang; ZhongGuang Wen; YiJiang Huang
![](/themes/default/image/downing1.png) 收藏  |  浏览/下载:16/0  |  提交时间:2019/12/19 |
| AChineseboyofWolf-HirschhornsyndromediagnosedbyCMA:casereportandliteraturereview 会议论文 作者: Xiaonan Du; Yu An; Xiaohong Guo; Li Zhang; Yi Wang
![](/themes/default/image/downing1.png) 收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19 |
| AcaseofoneChineseboyofWolf-HirschhornsyndromediagnosedbyCMA 会议论文 作者: Xiaonan Du; Yu An; Xiaohong Guo; Li Zhang; Yi Wang
![](/themes/default/image/downing1.png) 收藏  |  浏览/下载:1/0  |  提交时间:2019/12/19 |